United States

Ventyx Biosciences is a biopharmaceutical company that develops small molecule product candidates for inflammatory diseases. Its lead product candidate is VTX958 for psoriasis, psoriatic arthritis, and Crohn's disease. The company is also developing VTX002 for ulcerative colitis, VTX2735 for cryopyrin-associated periodic syndrome, and VTX3232 for CNS-penetrant NLRP3 inhibition. Founded in 2018, Ventyx Biosciences is based in Encinitas, California.

Ventyx Biosciences

Biopharmaceutical company developing inflammatory disease treatments.

Google

Quản lý Sản phẩm

Chuyên gia Dữ liệu

Ventyx Biosciences

Ventyx Biosciences Vị trí đang tuyển

Bạn đã sẵn sàng thăng tiến sự nghiệp? Hãy xem các vị trí đang mở tại Ventyx Biosciences.